Background: Type 2 diabetes is an independent risk factor for chronic liver disease, however disease burden estimates and knowledge of prognostic indicators are lacking in community populations.Aims: To describe the prevalence and incidence of clinically significant chronic liver disease amongst community-based older people with Type 2 diabetes and to determine risk factors which might assist in discriminating patients with unknown prevalent or incident disease.Design: Prospective cohort study.Methods: Nine hundred and thirty-nine participants in the Edinburgh Type 2 Diabetes Study underwent investigation including liver ultrasound and non-invasive measures of non-alcoholic steatohepatitis (NASH), hepatic fibrosis and systemic inflammation....
International audienceBackground: The epidemiology and natural history of non-alcoholic fatty liver ...
BackgroundThe incidence of cirrhosis and hepatocellular carcinoma (HCC) is increased in Type 2 diabe...
Diabetics have a higher risk of developing nonalcoholic fatty liver disease (NAFLD) and associated c...
Background: Type 2 diabetes is an independent risk factor for chronic liver disease, however disease...
INTRODUCTION: In people with Type 2 diabetes; chronic liver disease, particularly non-alcoholic fatt...
Increasingly chronic liver disease is being acknowledged as a complication of type 2 diabetes, in p...
Background & aims: the impact of type 2 diabetes (T2DM) on hospital admissions and deaths due to...
Background & Aims: Type 2 diabetes is a major driver of fatty liver disease and its long-term co...
Aim: To evaluate risk of liver fibrosis in patients with type 2 diabetes referred to a primary care ...
BACKGROUND AND AIMS: Most data on liver assessment in type 2 diabetes mellitus (T2DM) patients are f...
Abstract Background Risk factors underlying the development and progression of some of the less well...
BACKGROUND AND AIMS: There are uncertainties on the burden of liver disease in patients with type-2 ...
As morbidity and mortality related to potentially preventable liver diseases are on the rise globall...
BackgroundThe incidence of cirrhosis and hepatocellular carcinoma (HCC) is increased in Type 2 diabe...
Background: Non-alcoholic fatty liver disease (NAFLD) is a common association of Type 2 diabetes mel...
International audienceBackground: The epidemiology and natural history of non-alcoholic fatty liver ...
BackgroundThe incidence of cirrhosis and hepatocellular carcinoma (HCC) is increased in Type 2 diabe...
Diabetics have a higher risk of developing nonalcoholic fatty liver disease (NAFLD) and associated c...
Background: Type 2 diabetes is an independent risk factor for chronic liver disease, however disease...
INTRODUCTION: In people with Type 2 diabetes; chronic liver disease, particularly non-alcoholic fatt...
Increasingly chronic liver disease is being acknowledged as a complication of type 2 diabetes, in p...
Background & aims: the impact of type 2 diabetes (T2DM) on hospital admissions and deaths due to...
Background & Aims: Type 2 diabetes is a major driver of fatty liver disease and its long-term co...
Aim: To evaluate risk of liver fibrosis in patients with type 2 diabetes referred to a primary care ...
BACKGROUND AND AIMS: Most data on liver assessment in type 2 diabetes mellitus (T2DM) patients are f...
Abstract Background Risk factors underlying the development and progression of some of the less well...
BACKGROUND AND AIMS: There are uncertainties on the burden of liver disease in patients with type-2 ...
As morbidity and mortality related to potentially preventable liver diseases are on the rise globall...
BackgroundThe incidence of cirrhosis and hepatocellular carcinoma (HCC) is increased in Type 2 diabe...
Background: Non-alcoholic fatty liver disease (NAFLD) is a common association of Type 2 diabetes mel...
International audienceBackground: The epidemiology and natural history of non-alcoholic fatty liver ...
BackgroundThe incidence of cirrhosis and hepatocellular carcinoma (HCC) is increased in Type 2 diabe...
Diabetics have a higher risk of developing nonalcoholic fatty liver disease (NAFLD) and associated c...